Related Experiment Video

Updated: Aug 22, 2026

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors

L Nathan Tumey1, Bayard Huck, Elizabeth Gleason

  • 1Athersys, Inc., 3201 Carnegie Ave., Cleveland, OH 44115, USA. ntumey@athersys.com

Bioorganic & Medicinal Chemistry Letters
|September 3, 2004
PubMed

Insights

Researchers identified novel 2,4-diketobutyric acid compounds that inhibit Flap endonuclease 1 (FEN1). These inhibitors show potential for chemopotentiation by blocking DNA repair pathways in cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • DNA repair mechanisms are crucial for maintaining genomic stability.
  • Inhibition of DNA repair pathways is a promising strategy for cancer chemopotentiation.
  • Flap endonuclease 1 (FEN1) is a key enzyme in the Base Excision Repair (BER) pathway.

Purpose of the Study:

  • To identify and characterize novel inhibitors of Flap endonuclease 1 (FEN1).
  • To explore the structure-activity relationship (SAR) of 2,4-diketobutyric acid derivatives as FEN1 inhibitors.

Main Methods:

  • Synthesis of a series of 2,4-diketobutyric acid compounds.
  • Biochemical assays to evaluate FEN1 inhibitory activity.
  • Structure-activity relationship (SAR) analysis.

Main Results:

  • Identification of potent 2,4-diketobutyric acid derivatives as FEN1 inhibitors.
  • Detailed SAR studies elucidated key structural features for inhibitory activity.
  • Demonstration of FEN1 inhibition by the identified compounds.

Conclusions:

  • 2,4-Diketobutyric acid derivatives represent a promising class of FEN1 inhibitors.
  • These inhibitors have potential applications in enhancing the efficacy of chemotherapeutic agents.
  • Targeting FEN1 via these inhibitors offers a viable strategy for cancer treatment.

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...